HCAT
Health Catalyst Inc
Stock NASDAQ – Stock Market Prices, News & Analysis
Health Catalyst Inc provides data and analytic solutions to improve the performance of healthcare organizations.
Health Catalyst Inc
HCAT
Health Catalyst Inc provides data and analytic solutions to improve the performance of healthcare organizations.
Price history of Health Catalyst Inc
Price history of Health Catalyst Inc
Performance & Momentum
Health Catalyst Downgraded by Wells Fargo
Health Catalyst is under added pressure after Wells Fargo cut its rating to "Equal Weight" from "Overweight" and slashed its price target from $5 to $1. The bank said recent strategic changes and asset sales are unlikely to be enough to revive performance, amid declining revenue and margin pressure. The downgrade follows mixed results, with quarterly revenue falling year over year and guidance also coming in below market expectations. The stock could remain volatile in the near term as investors look for clear signs of an operational turnaround and margin improvement.
Strategic Analysis
Health Catalyst Inc • 2026
Health Catalyst develops analytics and operational software for hospitals and healthcare networks, with a value proposition focused on improving clinical and operational performance. Its positioning is based on leveraging healthcare data and AI to help providers better measure, prioritize, and execute decisions in a market where regulatory and organizational complexity favors specialized solutions.
- Niche expertise in healthcare data, difficult for generalist software vendors to replicate
- Useful positioning for hospital clients seeking efficiency gains and better care quality
- Exposure to the digitization of the U.S. healthcare system and to the growing use of AI applied to medical data
- Momentum is very weak, signaling low market confidence and limited near-term re-rating potential
- Highly sensitive to healthcare providers' budget decisions and to competitive pressure in specialized software
Momentum is clearly weak and the trend remains fragile, with significant underperformance across several time frames reflecting a lack of investor appetite for the stock. Recent rating downgrades by Wells Fargo reinforce this skepticism and may weigh on the medium-term outlook, even if they do not call into question the company's niche strategic positioning. For retail investors, the stock remains primarily a speculative turnaround story rather than a momentum name.
Similar stocks to Health Catalyst Inc
Recent News
Health Catalyst Inc
Health Catalyst to report Q3 results, eyes performance
5 months agoHealth Catalyst, a specialist in healthcare data analytics, will release its third-quarter results after market close on Monday. Investors will closely watch these figures to assess the company's ability to meet Wall Street expectations on revenue and profitability amid a competitive and volatile landscape for medical data firms. These results could significantly impact HCAT's stock valuation depending on whether set targets are met.
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
